Even after his passing in 2024, billionaire investor and mathematician Jim Simons remains known as the "Quant King" of hedge funds due to the extraordinary success of Renaissance...
Keep Reading →
May 11 - Hedge Funds, News
With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.
Keep Reading →
March 30 - Hedge Funds, News
After being in the green for a few trading sessions, the broader market index slid 0.8% on Wednesday, and blue-chip companies declined 0.1%.
Keep Reading →
March 26 - Insider Trading, News
In the US, healthcare expenditures and costs have been increasing.
Keep Reading →
March 12 - Hedge Funds, News
The American quant hedge fund Renaissance Technologies is known for using statistical and mathematical tools to drive its investment programs.
Keep Reading →
February 22 - Hedge Funds, News
Biotechnology stocks are among the most volatile in the market due to their high risk.
Keep Reading →
February 11 - Hedge Funds, News
Investing in healthcare equities is typically seen as protective during recessionary times.
Keep Reading →
December 28 - Hedge Funds, News
The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.
Keep Reading →
December 23 - Hedge Funds, News
Renaissance Technologies is an American hedge fund that specializes in systematic trading and employs statistical and mathematical tools to drive its investment programs.
Keep Reading →
October 6 - Hedge Funds, News
The current market data shows that the economy of the United States is normalizing, especially with an active Federal Reserve, global stimulus from China, and higher consumption...
Keep Reading →
September 30 - Hedge Funds, News
Recent discussions among financial strategists emphasize the current stock market dynamics, particularly regarding the upcoming US elections.
Keep Reading →
September 18 - Hedge Funds, Industries, News
In this article, we will be taking a look at the 30 Most Profitable Companies with Highest Margins in the World.
Keep Reading →
May 3 - Business, Industries, Lists, News
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Keep Reading →
March 17 - Lists, News
In this article, we discuss 5 most undervalued biotech stocks to buy according to hedge funds.
Keep Reading →
March 9 - News
In this article, we discuss the 15 undervalued defensive stocks for 2024.
Keep Reading →
December 24 - Hedge Funds, News
In this article, we discuss Jim Simons and his top 10 stock picks.
Keep Reading →
December 8 - Hedge Funds, News
In this piece, we will take a look at the five biggest healthcare stocks in Jim Simons' stock portfolio.
Keep Reading →
November 13 - Hedge Funds, News
In this article, we will be taking a look at the top 20 drug companies in the US by revenue.
Keep Reading →
November 9 - Industries, Lists, News
In this piece, we will take a look at five cheap biotechnology stocks that smart investors are piling into.
Keep Reading →
October 20 - Hedge Funds
In this piece, we will take a look at 14 best biotechnology stocks to buy according to hedge funds.
Keep Reading →
May 25 - Hedge Funds, News
In this article, we discuss billionaire Jim Simons’ top 15 stock picks in 2023.
Keep Reading →
May 19 - Hedge Funds, News
One industry that has rapidly evolved with time and impacted millions, if not billions, of lives is the pharmaceutical sector.
Keep Reading →
February 23 - Lists, News
In this article, we will be taking a look at 12 cheap biotech stocks to buy.
Keep Reading →
January 25 - Hedge Funds, News
The healthcare sector in 2022 outperformed the market despite several headwinds and a negative macroeconomic backdrop.
Keep Reading →
January 21 - Hedge Funds, News
Below we take a look at Jim Simons Stock Portfolio: 5 Biggest Healthcare Stocks.
Keep Reading →
December 31 - Hedge Funds, News
In this article, we discuss 5 best biotech stocks to buy according to hedge funds.
Keep Reading →
November 25 - Hedge Funds, News
In this article, we discuss 10 defensive stocks that quant billionaire Jim Simons loves.
Keep Reading →
September 21 - Hedge Funds, News
In this article, we will take a look at the 10 best Biotech stocks to buy now.
Keep Reading →
August 29 - Hedge Funds, News
In this article, we discuss 5 stocks that Thomas Steyer’s Farallon Capital is buying.
Keep Reading →
April 20 - Hedge Funds, News
In this article, we will be looking at the 3 medical stocks to buy according to Mitchell Blutt's Consonance Capital.
Keep Reading →
February 15 - Hedge Funds, News
In this article, we discuss 10 biotech stocks to buy according to Matthew Strobeck's Birchview Capital.
Keep Reading →
February 3 - Hedge Funds, News
In this article, we discuss the 5 best stocks to buy for 2022 according to analysts.
Keep Reading →
December 6 - Hedge Funds, News
In this article, we discuss the 5 best healthcare stocks to buy according to Greg Martinez's Parkman Healthcare Partners.
Keep Reading →
December 4 - Hedge Funds, News
In this article, we discuss the top 5 stocks in Dov Gertzulin's portfolio.
Keep Reading →
November 7 - Hedge Funds, News
In this article, we discuss Richard Pzena’s 9 new stock picks.
Keep Reading →
October 24 - Hedge Funds, News
In this article, we will take a look at 15 biotech and pharmaceutical stocks to buy according to Palo Alto Investors.
Keep Reading →
October 23 - Hedge Funds, News
At the moment, there are a multitude of metrics market participants can use to monitor publicly traded companies.
Keep Reading →
April 9 - News
Is Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY) the right pick for your portfolio? Prominent investors are in a bearish mood.
Keep Reading →
April 6 - News
